| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abstracts
|
|
|
2010
|
19 |
4 |
p. 496-546
|
artikel
|
| 2 |
Antiphospholipid antibodies and the protein C pathway
|
Urbanus, RT
|
|
2010
|
19 |
4 |
p. 394-399
|
artikel
|
| 3 |
Anti-phospholipid antibody mediated fetal loss: still an open question from a pathogenic point of view
|
Meroni, PL
|
|
2010
|
19 |
4 |
p. 453-456
|
artikel
|
| 4 |
Antiphospholipid antibody profile: implications for the evaluation and management of patients
|
Tincani, A.
|
|
2010
|
19 |
4 |
p. 432-435
|
artikel
|
| 5 |
Antiphospholipid syndrome and the brain in pediatric and adult patients
|
Muscal, E.
|
|
2010
|
19 |
4 |
p. 406-411
|
artikel
|
| 6 |
Antiphospholipid syndrome: critical analysis of the diagnostic path
|
Pengo, V.
|
|
2010
|
19 |
4 |
p. 428-431
|
artikel
|
| 7 |
Antiphospholipid syndrome (Hughes syndrome): 10 clinical topics
|
Hughes, GRV
|
|
2010
|
19 |
4 |
p. 343-346
|
artikel
|
| 8 |
Antiphospholipid syndrome treatment beyond anticoagulation: are we there yet?
|
Pierangeli, SS
|
|
2010
|
19 |
4 |
p. 475-485
|
artikel
|
| 9 |
Antiprothrombin antibody: why do we need more assays?
|
Atsumi, T.
|
|
2010
|
19 |
4 |
p. 436-439
|
artikel
|
| 10 |
Antithrombotic treatment failures in antiphospholipid syndrome: the new anticoagulants?
|
Cohen, H.
|
|
2010
|
19 |
4 |
p. 486-491
|
artikel
|
| 11 |
Authors Index
|
|
|
2010
|
19 |
4 |
p. 547-550
|
artikel
|
| 12 |
Autoimmunity, infection and adjuvants
|
Rose, NR
|
|
2010
|
19 |
4 |
p. 354-358
|
artikel
|
| 13 |
Catastrophic antiphospholipid syndrome (CAPS): update from the ‘CAPS Registry’
|
Cervera, R.
|
|
2010
|
19 |
4 |
p. 412-418
|
artikel
|
| 14 |
Domain I of β2-glycoprotein I: its role as an epitope and the potential to be developed as a specific target for the treatment of the antiphospholipid syndrome
|
Ioannou, Y.
|
|
2010
|
19 |
4 |
p. 400-405
|
artikel
|
| 15 |
Non-criteria manifestations of antiphospholipid syndrome
|
Erkan, D.
|
|
2010
|
19 |
4 |
p. 424-427
|
artikel
|
| 16 |
Obstetric antiphospholipid syndrome: current uncertainties should guide our way
|
Branch, DW
|
|
2010
|
19 |
4 |
p. 446-452
|
artikel
|
| 17 |
Obstetric antiphospholipid syndrome: still a challenge
|
Levy, RA
|
|
2010
|
19 |
4 |
p. 457-459
|
artikel
|
| 18 |
Pathophysiology of β2-glycoprotein I in antiphospholipid syndrome
|
Matsuura, E.
|
|
2010
|
19 |
4 |
p. 379-384
|
artikel
|
| 19 |
Proteomics in antiphospholipid syndrome: a review
|
Cuadrado, MJ
|
|
2010
|
19 |
4 |
p. 385-388
|
artikel
|
| 20 |
Risky business: the interpretation, use, and abuse of antiphospholipid antibody tests in clinical practice
|
Roubey, RAS
|
|
2010
|
19 |
4 |
p. 440-445
|
artikel
|
| 21 |
Role of tissue factor in thrombosis in antiphospholipid antibody syndrome
|
Boles, J.
|
|
2010
|
19 |
4 |
p. 370-378
|
artikel
|
| 22 |
Some antiphospholipid antibodies bind to various serine proteases in hemostasis and tip the balance toward hypercoagulant states
|
Chen, PP
|
|
2010
|
19 |
4 |
p. 365-369
|
artikel
|
| 23 |
Speakers Abstracts
|
|
|
2010
|
19 |
4 |
p. 492-495
|
artikel
|
| 24 |
The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis
|
Rand, JH
|
|
2010
|
19 |
4 |
p. 460-469
|
artikel
|
| 25 |
The dual role of innate immunity in the antiphospholipid syndrome
|
Rauch, J.
|
|
2010
|
19 |
4 |
p. 347-353
|
artikel
|
| 26 |
The role of LRP8 (ApoER2’) in the pathophysiology of the antiphospholipid syndrome
|
de Groot, PG
|
|
2010
|
19 |
4 |
p. 389-393
|
artikel
|
| 27 |
Towards evidence-based treatment of thrombotic antiphospholipid syndrome
|
Derksen, Rhwm
|
|
2010
|
19 |
4 |
p. 470-474
|
artikel
|
| 28 |
Update on anti-phospholipid antibodies in SLE: the Hopkins’ Lupus Cohort
|
Petri, M.
|
|
2010
|
19 |
4 |
p. 419-423
|
artikel
|
| 29 |
Use of monoclonal antibodies to dissect specificity and pathogenesis of antiphospholipid antibodies
|
Lambrianides, A.
|
|
2010
|
19 |
4 |
p. 359-364
|
artikel
|
Tijdschrift beschrijving